Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

REPL

Replimune Group Inc

May 01 • 04:00PM ET

2.50

-0.07 -2.72 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: MRNA BNTX FATE SGMO KPTI ALVR PGEN ADAP ANIX ENTX

| Held by: VTI VXF XBI IWM VTWO IWN IBB FESM VHT SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.58	Insider Own	7.82%	Shs Outstand	79.63M	Perf Week	3.31%
Market Cap	206.43M	Forward P/E	-	EPS next Y	-1.63	Insider Trans	-0.50%	Shs Float	76.12M	Perf Month	-67.15%
Enterprise Value	13.64M	PEG	-	EPS next Q	-0.65	Inst Own	93.63%	Short Float	24.21%	Perf Quarter	-64.44%
Income	-314.85M	P/S	-	EPS this Y	0.77%	Inst Trans	-2.48%	Short Ratio	4.02	Perf Half Y	-75.51%
Sales	0.00M	P/B	0.95	EPS next Y	46.40%	ROA	-67.19%	Short Interest	18.43M	Perf YTD	-74.28%
Book/sh	2.64	P/C	0.77	EPS next 5Y	33.42%	ROE	-90.88%	52W High	13.24 -81.12%	Perf Year	-74.07%
Cash/sh	3.26	P/FCF	-	EPS past 3/5Y	-10.73% -14.85%	ROIC	-111.33%	52W Low	1.50 66.67%	Perf 3Y	-85.71%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.41% 17.93%	Perf 5Y	-93.17%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-13.96%	Oper. Margin	-	ATR (14)	0.56	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.60	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	34.93	Recom	3.50
Dividend Gr. 3/5Y	- -	Current Ratio	5.60	EPS Q/Q	3.16%	SMA20	-25.77%	Beta	0.12	Target Price	2.20
Payout	-	Debt/Eq	0.36	Sales Q/Q	-	SMA50	-57.57%	Rel Volume	0.76	Prev Close	2.57
Employees	479	LT Debt/Eq	0.34	Earnings	Feb 03 BMO	SMA200	-63.95%	Avg Volume	4.58M	Price	2.50
IPO	Jul 20, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.89% 0.00%	Trades		Volume	3,466,258	Change	-2.72%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)